Verastem Oncology is committed to advancing cancer treatment for patients with RAS/MAPK pathway mutations, a significant driver of tumor growth and resistance. Their innovative therapies, like the FDA-approved AVMAPKI FAKZYNJA CO-PACK, specifically target recurrent KRAS-mutated low-grade serous ovarian cancer, addressing a critical unmet need in oncology. With ongoing clinical trials and an expanding pipeline, Verastem is poised to make a substantial impact in the evolving landscape of cancer care.
No jobs found
Try different keywords or remove some filters.
Or create a free account and we’ll email you when new jobs match what you’re looking for.
Create a free account
Searching
Want job alerts that match your preferences?
Set up job preferences →